Matches in Nanopublications for { ?s ?p "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP74720.RA1Mq70Sd485P7gm9uRjaKcFCB7zHIVfy9iAFyJSnIFsk130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74720.RA1Mq70Sd485P7gm9uRjaKcFCB7zHIVfy9iAFyJSnIFsk130_provenance.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.
- assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP139641.RAa0bGT4hCsTIpQ7e6xQq5uHkS4IVMng94Kc8zukWciuY130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139641.RAa0bGT4hCsTIpQ7e6xQq5uHkS4IVMng94Kc8zukWciuY130_provenance.
- NP111221.RAlTRwBV1nFNHV6CZtVGByxmIu5MiGQLKxGGDwQYMjOMM130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111221.RAlTRwBV1nFNHV6CZtVGByxmIu5MiGQLKxGGDwQYMjOMM130_provenance.
- NP111222.RAhbeR440QngrwiKHMotx85hhFQde6BNTojTH6N5ttykc130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111222.RAhbeR440QngrwiKHMotx85hhFQde6BNTojTH6N5ttykc130_provenance.
- NP106879.RAMp_s8STrMULqWm5LLbFcN2kI2IPiDzftkaiRHBnZ3oU130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106879.RAMp_s8STrMULqWm5LLbFcN2kI2IPiDzftkaiRHBnZ3oU130_provenance.